Paulson & Co’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Paulson & Co’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,070,000	Closed	-$42.5M	–	117
2016 Q3	$42.5M	Buy	+1,070,000	New	+$11.9M	0.46%	35

Paulson & Co's TBRA Position: Q4 2016 in Review

Paulson & Co sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 1,070,000 shares — an estimated $42.5M sold.

Paulson & Co first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $42.5M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Paulson & Co reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Paulson & Co sold 1,070,000 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $42.5M.
Paulson & Co first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
Paulson & Co's Tobira Therapeutics, Inc. Common Stock position peaked at $42.5M in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Paulson & Co's 13F filing for Q4 2016, filed 14 Feb 2017.